AU2001248994A1 - Use of substances with oxytocin activity against climacteric disorders - Google Patents

Use of substances with oxytocin activity against climacteric disorders

Info

Publication number
AU2001248994A1
AU2001248994A1 AU2001248994A AU4899401A AU2001248994A1 AU 2001248994 A1 AU2001248994 A1 AU 2001248994A1 AU 2001248994 A AU2001248994 A AU 2001248994A AU 4899401 A AU4899401 A AU 4899401A AU 2001248994 A1 AU2001248994 A1 AU 2001248994A1
Authority
AU
Australia
Prior art keywords
activity against
substances
climacteric disorders
oxytocin activity
against climacteric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248994A
Inventor
Thomas Lundeberg
Kerstin Uvnas Moberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EntreTech Medical AB
Original Assignee
EntreTech Medical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EntreTech Medical AB filed Critical EntreTech Medical AB
Publication of AU2001248994A1 publication Critical patent/AU2001248994A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to the use of substances with oxytocin activity against climacteric disorders or similar symptoms due to dysfunction in the ovaries. It also relates to a pharmaceutical composition comprising at least one substance with oxytocin activity against climacteric disorders.
AU2001248994A 2000-04-18 2001-04-18 Use of substances with oxytocin activity against climacteric disorders Abandoned AU2001248994A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0001440 2000-04-18
SE0001440A SE0001440D0 (en) 2000-04-18 2000-04-18 A drug against climacteric disorders
PCT/SE2001/000854 WO2001078758A1 (en) 2000-04-18 2001-04-18 Use of substances with oxytocin activity against climacteric disorders

Publications (1)

Publication Number Publication Date
AU2001248994A1 true AU2001248994A1 (en) 2001-10-30

Family

ID=20279369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248994A Abandoned AU2001248994A1 (en) 2000-04-18 2001-04-18 Use of substances with oxytocin activity against climacteric disorders

Country Status (8)

Country Link
US (2) US20040029787A1 (en)
EP (1) EP1406649B9 (en)
AT (1) ATE387213T1 (en)
AU (1) AU2001248994A1 (en)
DE (1) DE60133050T2 (en)
ES (1) ES2302728T3 (en)
SE (1) SE0001440D0 (en)
WO (1) WO2001078758A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100684D0 (en) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject matter
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Peptidic Vasopressin Receptor Agonists
NZ569836A (en) 2006-02-10 2010-09-30 Ferring Bv Novel compounds
WO2009037586A2 (en) 2007-08-14 2009-03-26 Ferring B.V. Use of peptidic vasopressin receptor agonists
CA2704724A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag 5use of a peptide as a therapeutic agent
KR20100057046A (en) * 2007-09-11 2010-05-28 몬도바이오테크 래보래토리즈 아게 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
WO2009046865A2 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Cholecystokinin-33 alone or in combination with trap-14 as therapeutic agent
WO2009033820A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009043455A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Therapeutic uses of angiogenin 108-122 and gluten exorphin a5
SE536091C2 (en) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Pharmaceutical composition containing oxytocin or fragments or variants thereof and at least one non-ionic cellulose ether
EP2908840A1 (en) * 2012-10-12 2015-08-26 Peptonic Medical AB Novel use of a composition comprising oxytocin
SE1750680A1 (en) 2017-05-30 2018-12-01 Peptonic Medical Ab Composition for treating or preventing climacteric disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889844A (en) * 1985-10-22 1989-12-26 Silvetti Sr Anthony N Fructose containing wound healing preparation
CA2110176A1 (en) * 1992-03-28 1993-10-14 Akira Yanagawa Topical preparation for healing wounds of the skin
MY117988A (en) * 1995-10-03 2004-08-30 Nor Ind Inc Cleaning compositions for oil and gas well, lines, casings, formations and equipment and methods of use
US5753266A (en) * 1996-12-03 1998-05-19 Youssefyeh; Parvin Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
SE9701162D0 (en) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
SE9803272D0 (en) * 1998-09-25 1998-09-25 Kerstin Uvnaes Moberg A drug for cell regeneration
US6333313B1 (en) * 1998-10-29 2001-12-25 Board Of Regents, The University Of Texas System Clinical use of oxytocin alone or in combination to treat bone disorders
SE0100684D0 (en) 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject matter

Also Published As

Publication number Publication date
EP1406649B9 (en) 2008-10-15
DE60133050D1 (en) 2008-04-10
WO2001078758A1 (en) 2001-10-25
SE0001440D0 (en) 2000-04-18
US7727959B2 (en) 2010-06-01
DE60133050T2 (en) 2009-02-26
ES2302728T3 (en) 2008-08-01
ATE387213T1 (en) 2008-03-15
EP1406649A1 (en) 2004-04-14
US20060148685A1 (en) 2006-07-06
EP1406649B1 (en) 2008-02-27
US20040029787A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
WO2002016402A3 (en) Apoptotic compounds
IL218698A0 (en) Compounds that inhibit serine protease activity and pharmaceutical compositions containing the same
IL152315A0 (en) Soluble ctla4 mutant molecules and pharmaceutical compositions containing the same
MXPA03003705A (en) Self contained liquid atomizer assembly.
BRPI0112859B8 (en) somatostatin analogues, pharmaceutical composition, as well as the use of said analogues
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
WO2004089396A3 (en) Anti-fungal peptidomimetics
AP2003002916A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
EP1344780A4 (en) Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
DK1091975T3 (en) New cyclosporine with improved activity profile
IL152448A0 (en) 3-nitrogen-6, 7-dioxygen steroid derivatives and pharmaceutical compositions containing the same
BG106075A (en) Use of cyp2d6 inhibitors in combination therapies
IL175210A0 (en) Non-pancreatic proteases and pharmaceutical compositions containing the same
BR0009480A (en) Polyurethane solutions with alkoxysilane structure units
AU2001248994A1 (en) Use of substances with oxytocin activity against climacteric disorders
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
CA2270177A1 (en) Transdermal administration of ment
AU8738401A (en) Novel kallikrein gene
IT1320080B1 (en) COMPOSITION FOR PHARMACEUTICAL OR DIETARY USE.
WO2002015959A3 (en) Compounds and compositions for delivering active agents
IL139318A (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
BG106316A (en) Ambroxol-containing lozenge
SE9803272D0 (en) A drug for cell regeneration
AU2001278680A1 (en) Erectile dysfunction remedies containing prostaglandin derivatives as the activeingredient